MedicineDermatologyAllergyDermatologic SurgeryHypersensitivityBotulinum Toxin TherapyBotulinum Toxin TreatmentSkin SafetyBotulinum NeurotoxinBotulinum ToxinsPore Size ControlPore Size RegulationPore-size DistributionPoresProduct Safety ProfileSebum Production
OBJECTIVE: Review the safety profile and subjective efficacy of intradermal botulinum toxin type A in facial pore size and sebum production. DESIGN: Retrospective analysis of 20 patients. RESULTS: Twenty consecutive patients with a single application of intradermal botulinum toxin type A were examined: Patients (17/20) noted an improvement in sebum production and a decrease in pores size at 1 month after injection. No complications were observed, and 17/20 patients were satisfied with the procedure. CONCLUSION: Preliminary data suggests that intradermal botulinum toxin may play a role in decreasing sebum production. Further quantitive study may be necessary to determine effects of intradermal botulinum toxin on pore size.